X hits on this document





46 / 49

Page 285

Weintraub et al

Syndromes dinsuffisance cardiaque aiguë


  • 147.

    Jondeau G, Neuder Y, Eicher JC, Jourdain P, Fauveau E, Galinier M, Jegou A, Bauer F, Trochu JN, Bouzamondo A, Tanguy ML, Lechat P; B-CONVINCED Investigators. B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J. 2009;30:21862192.

  • 148.

    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, OConnor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Coordinators. Influence of beta- blocker continuation or withdrawal on outcomes in patients hospital- ized with heart failure: findings from the OPTIMIZE-HF program. J Am Coll Cardiol. 2008;52:190199.

  • 149.

    Rodgers JE, Stough WG. Underutilization of evidence-based therapies in heart failure: the pharmacists role. Pharmacotherapy. 2007;27 (pt 2):18S28S.

  • 150.

    Coons JC, Fera T. Multidisciplinary team for enhancing care for patients with acute myocardial infarction or heart failure. Am J Health Syst Pharm. 2007;64:12741278.

  • 151.

    Naylor MD, Bowles KH, Brooten D. Patient problems and advanced practice nurse interventions during transitional care. Public Health Nurs. 2000;17:94102.

  • 152.

    Paul S. Hospital discharge education for patients with heart failure: what really works and what is the evidence? Crit Care Nurse. 2008;28:6682.

  • 153.

    Konick-McMahan J, Bixby B, McKenna C. Heart failure in older adults: providing nursing care to improve outcomes. J Gerontol Nurs. 2003;29:3541.

  • 154.

    Williams S, Brown A, Patton R, Crawford MJ, Touquet R. The half-life of the teachable momentfor alcohol misusing patients in the emergency department. Drug Alcohol Depend. 2005;77:205208.

  • 155.

    The Joint Commission. Performance measurement initiatives. Heart failure core measure set. Available at: http://www.jointcommission.org/ PerformanceMeasurement/PerformanceMeasurement/Heart+Failure+ Core+Measure+Set.htm. Accessed November 9, 2009.

  • 156.

    Albert NM. Promoting self-care in heart failure: state of clinical practice based on the perspectives of healthcare systems and providers. J Cardiovasc Nurs. 2008;23:277284.

  • 157.

    Moser DK, Watkins JF. Conceptualizing self-care in heart failure: a life course model of patient characteristics. J Cardiovasc Nurs. 2008;23:205218.

  • 158.

    Dunbar SB, Clark PC, Quinn C, Gary RA, Kaslow NJ. Family influences on heart failure self-care and outcomes. J Cardiovasc Nurs. 2008;23:258265.

  • 159.

    Arslanian-Engoren C, Hicks FD, Whall AL, Algase DL. An ontological view of advanced practice nursing. Res Theory Nurs Pract. 2005;19:315322.

  • 160.

    Naylor MD, Brooten DA, Campbell RL, Maislin G, McCauley KM, Schwartz JS. Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial. J Am Geriatr Soc. 2004;52: 675684.

  • 161.

    McCauley KM, Bixby MB, Naylor MD. Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure. Dis Manag. 2006;9:302310.

  • 162.

    Berdague P, Caffin PY, Barazer I, Vergnes C, Sedighian S, Letrillard S, Pilossof R, Goutorbe F, Piot C, Reny JL. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. Am Heart J. 2006;151:690698.

  • 163.

    Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J. 2005;149:744750.

  • 164.

    Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Maisel AS. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J. 2006;151:9991005.

  • 165.

    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol. 2006;47:9197.

  • 166.

    Logeart D, Saudubray C, Beyne P, Thabut G, Ennezat PV, Chavelas C, Zanker C, Bouvier E, Solal AC. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol. 2002;40:17941800.

  • 167.

    Steinhart B, Thorpe KE, Bayoumi AM, Moe G, Januzzi JL Jr, Mazer

    • CD.

      Improving the diagnosis of acute heart failure using a validated prediction model. J Am Coll Cardiol. 2009;54:15151521.

  • 168.

    Brophy J. ACP Journal Club. A model combining clinical assessment and NT-proBNP level accurately predicted heart failure in ED patients with dyspnea. Ann Intern Med. 2010;152:JC1JC13.

  • 169.

    Dickstein K. Diagnosing acute heart failure: the mathematician and the clinician. J Am Coll Cardiol. 2009;54:15221523.

  • 170.

    Collins SP, Peacock WF, Lindsell CJ, Clopton P, Diercks DB, Hiestand B, Hogan C, Kontos MC, Mueller C, Nowak R, Chen WJ, Huang CH, Abraham WT, Amsterdam E, Breidthardt T, Daniels L, Hasan A, Hudson M, McCord J, Naz T, Wagoner LE, Maisel A. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med. 2009;53:748757.

  • 171.

    Collins SP, Lindsell CJ, Peacock WF, Hedger VD, Askew J, Eckert DC, Storrow AB. The combined utility of an S3 heart sound and B-type natriuretic peptide levels in emergency department patients with dyspnea. J Card Fail. 2006;12:286292.

  • 172.

    Peacock WF, Harrison A, Moffa D. Clinical and economic benefits of using AUDICOR S3 detection for diagnosis and treatment of acute decompensated heart failure. Congest Heart Fail. 2006;12(suppl 1): 3236.

  • 173.

    Peacock WF, Summers RL, Vogel J, Emerman CE. Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. Acad Emerg Med. 2006;13:365371.

  • 174.

    Kamath SA, Drazner MH, Tasissa G, Rogers JG, Stevenson LW, Yancy CW. Correlation of impedance cardiography with invasive hemo- dynamic measurements in patients with advanced heart failure: the BioImpedance CardioGraphy (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trial. Am Heart J. 2009;158:217223.

  • 175.

    Copetti R, Soldati G, Copetti P. Chest sonography: a useful tool to differentiate acute cardiogenic pulmonary edema from acute respiratory distress syndrome. Cardiovasc Ultrasound. 2008;6:16.

  • 176.

    Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E. Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail. 2008;10:7077.

  • 177.

    Soldati G, Gargani L, Silva FR. Acute heart failure: new diagnostic per- spectives for the emergency physician. Intern Emerg Med. 2008;3: 3741.

  • 178.

    Klemen P, Golub M, Grmec S. Combination of quantitative capnom- etry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy. Croat Med J. 2009;50:133142.

  • 179.

    Felker GM, Cuculich PS, Gheorghiade M. The Valsalva maneuver: a bedside biomarkerfor heart failure. Am J Med. 2006;119:117122.

  • 180.

    Sharma GV, Woods PA, Lambrew CT, Berg CM, Pietro DA, Rocco TP, Welt FW, Sacchetti P, McIntyre KM. Evaluation of a noninvasive system for determining left ventricular filling pressure. Arch Intern Med. 2002;162:20842088.

  • 181.

    Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer

      • S.

        The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54:14071424.

  • 182.

    Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen- Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treat- ment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA). Eur Heart J. 2008;29:23882442.

  • 183.

    Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol. 2007;50:381396.


Page 285

Document info
Document views96
Page views96
Page last viewedWed Oct 26 01:03:23 UTC 2016